Skip to content

Press Releases

Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.

Medifast's Board of Directors Approves Stock Buyback

Medifast, Inc. announced today that its Board of Directors has authorized a stock buyback of up to 200,000 shares of its common stock. The buyback authorization allows the company to make purchases from time to time on the open market at prevailing prices or in privately negotiated transactions. Medifast's management will make the purchase decisions based upon market conditions and other considerations.

"We continue to successfully implement many of the initiatives that we expect to drive significant revenue and earnings growth throughout the year," said Brad MacDonald, Medifast's Chairman and Chief Executive Officer. "We have increased our Hi-Energy clinic business significantly, grown our Take Shape for Life division and made progress in developing new markets for our products. We believe the current valuation of the company does not fairly reflect our prospects for growth."

This release contains forward-looking statements that may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectations or beliefs on this date.

SOURCE: Medifast, Inc.

CONTACT: Jeremy Hunt, Investor Relations Specialist, +1-410-504-8196, or
Casey Seward, Public Relations Manager, +1-410-504-8154, both of Medifast,
Inc.; or Ken Sgro, CEOcast, Inc. for Medifast, +1-212-732-4300